Adi Mor
Immunology
Chemomab
Israel
Biography
Adi Mor is the co-founder and CEO of ChemomAb since 2011. Adi has extensive knowledge and experience in the fields of immunology, autoimmune and inflammatory diseases and a wide experience in designing, promoting and patenting a novel class of monoclonal antibodies to treat inflammatory and cancer diseases. Adi completed her Ph.D. in Immunology from the Tel Aviv University in the Department of Neurobiochemistry and is a lead author of multiple publications in scientific journals in the fields of immunology and inflammatory disorders. Adi Mor is the co-founder and CEO of ChemomAb since 2011. Adi has extensive knowledge and experience in the fields of immunology, autoimmune and inflammatory diseases and a wide experience in designing, promoting and patenting a novel class of monoclonal antibodies to treat inflammatory and cancer diseases. Adi completed her Ph.D. in Immunology from the Tel Aviv University in the Department of Neurobiochemistry and is a lead author of multiple publications in scientific journals in the fields of immunology and inflammatory disorders.
Research Interest
Immunology
